23andMe Holding Co - Warrants (16/06/2026) Profit Margin

The latest profit margin for MEUSW is -134.54% as of June 2025. That compares with -317.03% in the prior-year period — up 57.6% year over year. That is below the Healthcare sector average of 13.76%. Investors often review this figure alongside 23andMe Holding Co - Warrants (16/06/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, MEUSW's profit margin moved from -317.03% to -134.54% — a 57.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 23andMe Holding Co - Warrants (16/06/2026)'s valuation or profitability profile.

Against Healthcare companies, MEUSW currently prints -134.54% for profit margin, while the sector average sits near 13.76%. That is roughly 1077.7% below the sector mean. Large gaps often invite a closer look at 23andMe Holding Co - Warrants (16/06/2026)'s growth, margins, and balance sheet.

Profit Margin shows how effectively 23andMe Holding Co - Warrants (16/06/2026) converts resources into returns. At -134.54%, MEUSW may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -317.03% in the prior-year period — up 57.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting MEUSW's profit margin (-134.54%), review year-over-year change from -317.03%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.